(Q46810913)

25 December 2017

title

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism (English)

1 reference

25 December 2017

0 references

1 reference

ChEBI release 2020-05-28

5

1 reference

25 December 2017

Gareth R. Jones

10

1 reference

25 December 2017

Colin L. Masters

23

object named as

Colin L Masters

1 reference

25 December 2017

Christopher C Rowe

1

1 reference

25 December 2017

Uwe Ackerman

2

1 reference

25 December 2017

William Browne

3

1 reference

25 December 2017

Rachel Mulligan

4

1 reference

25 December 2017

Graeme O'Keefe

6

1 reference

25 December 2017

Henry Tochon-Danguy

7

1 reference

25 December 2017

Gordon Chan

8

1 reference

25 December 2017

Salvatore U Berlangieri

9

1 reference

25 December 2017

Kerryn L Dickinson-Rowe

11

1 reference

25 December 2017

Hank P Kung

12

1 reference

25 December 2017

Wei Zhang

13

1 reference

25 December 2017

Mei Ping Kung

14

1 reference

25 December 2017

Daniel Skovronsky

15

1 reference

25 December 2017

Thomas Dyrks

16

1 reference

25 December 2017

Gerhard Holl

17

1 reference

25 December 2017

Sabine Krause

18

1 reference

25 December 2017

Matthias Friebe

19

1 reference

25 December 2017

Lutz Lehman

20

1 reference

25 December 2017

Stefanie Lindemann

21

1 reference

25 December 2017

Ludger M Dinkelborg

22

1 reference

25 December 2017

Victor L Villemagne

24

1 reference

25 December 2017

publication date

10 January 2008

1 reference

25 December 2017

published in

Lancet Neurology

1 reference

25 December 2017

volume

7

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

129-135

1 reference

25 December 2017

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Imaging beta-amyloid burden in aging and dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

PET of brain amyloid and tau in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Neuropathology of older persons without cognitive impairment from two community-based studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Global prevalence of dementia: a Delphi consensus study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

Current and future uses of neuroimaging for cognitively impaired patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970001-2

7 January 2021

10.1016/S1474-4422(08)70001-2

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017